Skip to Content
Merck
  • T cell-intrinsic role for Nod2 in protection against Th17-mediated uveitis.

T cell-intrinsic role for Nod2 in protection against Th17-mediated uveitis.

Nature communications (2020-10-28)
Ruth J Napier, Ellen J Lee, Michael P Davey, Emily E Vance, João M Furtado, Paige E Snow, Kimberly A Samson, Sydney J Lashley, Brieanna R Brown, Reiko Horai, Mary J Mattapallil, Biying Xu, Michelle C Callegan, Luke S Uebelhoer, Christina L Lancioni, Richard K Vehe, Bryce A Binstadt, Justine R Smith, Rachel R Caspi, Holly L Rosenzweig
ABSTRACT

Mutations in nucleotide-binding oligomerization domain-containing protein 2 (NOD2) cause Blau syndrome, an inflammatory disorder characterized by uveitis. The antimicrobial functions of Nod2 are well-established, yet the cellular mechanisms by which dysregulated Nod2 causes uveitis remain unknown. Here, we report a non-conventional, T cell-intrinsic function for Nod2 in suppression of Th17 immunity and experimental uveitis. Reconstitution of lymphopenic hosts with Nod2-/- CD4+ T cells or retina-specific autoreactive CD4+ T cells lacking Nod2 reveals a T cell-autonomous, Rip2-independent mechanism for Nod2 in uveitis. In naive animals, Nod2 operates downstream of TCR ligation to suppress activation of memory CD4+ T cells that associate with an autoreactive-like profile involving IL-17 and Ccr7. Interestingly, CD4+ T cells from two Blau syndrome patients show elevated IL-17 and increased CCR7. Our data define Nod2 as a T cell-intrinsic rheostat of Th17 immunity, and open new avenues for T cell-based therapies for Nod2-associated disorders such as Blau syndrome.